Advances in aptamer-mediated targeted delivery system for cancer treatment
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in aptamer-mediated targeted delivery system for cancer treatment
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 238, Issue -, Pages 124173
Publisher
Elsevier BV
Online
2023-03-24
DOI
10.1016/j.ijbiomac.2023.124173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of novel aptamer-based targeted chemotherapy for bladder cancer
- (2022) Yao Wang et al. CANCER RESEARCH
- Albumin-Binding Aptamer Chimeras for Improved siRNA Bioavailability
- (2022) Jonah C. Rosch et al. Cellular and Molecular Bioengineering
- Progress in cancer drug delivery based on AS1411 oriented nanomaterials
- (2022) Xin Tong et al. JOURNAL OF NANOBIOTECHNOLOGY
- Transferrin Receptor-Mediated Internalization and Intracellular Fate of Conjugates of a DNA Aptamer
- (2022) Nan Zhang et al. Molecular Therapy-Nucleic Acids
- Inhibitory effect of aptamer-carbon dot nanomaterial-siRNA complex on the metastasis of hepatocellular carcinoma cells by interfering with FMRP
- (2022) Xiaoliang Zhao et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics
- (2022) Afsana Sheikh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Self-Assembly of a Multifunction DNA Tetrahedron for Effective Delivery of Aptamer PL1 and Pcsk9 siRNA Potentiate Immune Checkpoint Therapy for Colorectal Cancer
- (2022) Wenjing Guo et al. ACS Applied Materials & Interfaces
- Aptamer-conjugated carbon-based nanomaterials for cancer and bacteria theranostics: A review
- (2022) Saman Sargazi et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression
- (2022) Minhee Kim et al. JOURNAL OF CONTROLLED RELEASE
- AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer
- (2022) Nashmin Fayazi Hosseini et al. BIOMEDICINE & PHARMACOTHERAPY
- Stepwise responsive carboxymethyl chitosan-based nanoplatform for effective drug-resistant breast cancer suppression
- (2022) Hui Peng et al. CARBOHYDRATE POLYMERS
- Aptamer-conjugated nanoliposomes containing COL1A1 siRNA sensitize CRC cells to conventional chemotherapeutic drugs
- (2022) Hamed Manoochehri et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Tetrahedral Framework Nucleic Acids Loaded with Aptamer AS1411 for siRNA Delivery and Gene Silencing in Malignant Melanoma
- (2021) Dexuan Xiao et al. ACS Applied Materials & Interfaces
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 30 years of HER3: From basic biology to therapeutic interventions
- (2021) Heidi M. Haikala et al. CLINICAL CANCER RESEARCH
- Self-Assembled DNA Nanostructure as a Carrier for Targeted siRNA Delivery in Glioma Cells
- (2021) Yanghao Zhou et al. International Journal of Nanomedicine
- Antibody–drug conjugates in solid tumors: a look into novel targets
- (2021) Carmen Criscitiello et al. Journal of Hematology & Oncology
- Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown
- (2021) Ying Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Au-siRNA@ aptamer nanocages as a high-efficiency drug and gene delivery system for targeted lung cancer therapy
- (2021) Yuming Yang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Sequential Release of Pooled siRNAs and Paclitaxel by Aptamer-Functionalized Shell–Core Nanoparticles to Overcome Paclitaxel Resistance of Prostate Cancer
- (2021) Qianqian Guo et al. ACS Applied Materials & Interfaces
- Enhancing anti‐PD‐1 immunotherapy by nanomicelles self‐assembled from aptamer‐multivalent‐drug conjugates
- (2021) Zhongmin Geng et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Aptamer-Targeted Photodynamic Platforms for Tumor Therapy
- (2021) Jincong Yan et al. ACS Applied Materials & Interfaces
- Self-targeted polymersomal co-formulation of doxorubicin, camptothecin and FOXM1 aptamer for efficient treatment of non-small cell lung cancer
- (2021) Mahsa Shahriari et al. JOURNAL OF CONTROLLED RELEASE
- Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
- (2021) Lisa Agnello et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Nanoparticle-Mediated Inhibition of Mitochondrial Glutaminolysis to Amplify Oxidative Stress for Combination Cancer Therapy
- (2021) Lei Xu et al. NANO LETTERS
- Stepping forward in antibody-drug conjugate development
- (2021) Yiming Jin et al. PHARMACOLOGY & THERAPEUTICS
- PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies
- (2021) Yamin Jie et al. Frontiers in Immunology
- CD71-Specific Aptamer Conjugated with Monomethyl Auristatin E for the Treatment of Uveal Melanoma
- (2021) Hui Zhang et al. ACS Applied Materials & Interfaces
- Smart drug delivery of p-Coumaric acid loaded aptamer conjugated starch nanoparticles for effective triple-negative breast cancer therapy
- (2021) Arokia Vijaya Anand Mariadoss et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy
- (2021) Sonia Iranpour et al. JOURNAL OF NANOBIOTECHNOLOGY
- Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma
- (2020) Li Peng et al. International Journal of Nanomedicine
- Construction of Bispecific Aptamer–Drug Conjugate by a Hybrid Chemical and Biological Approach
- (2020) Yang Sun et al. BIOCONJUGATE CHEMISTRY
- Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy
- (2020) Kandasamy Saravanakumar et al. CARBOHYDRATE POLYMERS
- Profiling global cancer incidence and mortality by socioeconomic development
- (2020) Joannie Lortet‐Tieulent et al. INTERNATIONAL JOURNAL OF CANCER
- Generating Biologically Stable TNA Aptamers that Function with High Affinity and Thermal Stability
- (2020) Matthew R. Dunn et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3
- (2020) Carla Lucia Esposito et al. Cancers
- Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles
- (2020) Yougan Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- MUC1 Aptamer‐Capped Mesoporous Silica Nanoparticles for Navitoclax Resistance Overcoming in Triple‐Negative Breast Cancer
- (2020) Gema Vivo-Llorca et al. CHEMISTRY-A EUROPEAN JOURNAL
- Strategies to bioengineer aptamer-driven nanovehicles as exceptional molecular tools for targeted therapeutics: A review
- (2020) Ramesh Thevendran et al. JOURNAL OF CONTROLLED RELEASE
- Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapy
- (2020) Adriana De La Fuente et al. Science Translational Medicine
- Doxorubicin conjugated innovative 16-mer DNA aptamer based annexin A1 targeted anti-cancer drug delivery
- (2020) Rohit Bavi et al. Molecular Therapy-Nucleic Acids
- Targeted MMP-2 responsive chimeric polymersomes for therapy against colorectal cancer
- (2020) Pouria Ramezani et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel
- (2020) Zhen Yu et al. International Journal of Nanomedicine
- Development of HER2-Specific Aptamer-Drug Conjugate for Breast Cancer Therapy
- (2020) Hwa Yeon Jeong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EpCAM-Targeted 3WJ RNA Nanoparticle Harboring Delta-5-Desaturase siRNA Inhibited Lung Tumor Formation via DGLA Peroxidation
- (2020) Lizhi Pang et al. Molecular Therapy-Nucleic Acids
- Molecularly engineered truncated tissue factor with therapeutic aptamers for tumor-targeted delivery and vascular infarction
- (2020) Bozhao Li et al. Acta Pharmaceutica Sinica B
- Analysis of status and countermeasures of cancer incidence and mortality in China
- (2019) Chunchun Wu et al. Science China-Life Sciences
- Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells
- (2019) Keke Gui et al. BIOMEDICINE & PHARMACOTHERAPY
- Nanoparticle-mediated targeted drug delivery for breast cancer treatment
- (2019) Piumi Y. Liyanage et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Aptamer-functionalized liposomes for targeted cancer therapy
- (2019) Seyedeh Alia Moosavian et al. CANCER LETTERS
- Co-Delivery of Paclitaxel and PLK1-Targeted siRNA Using Aptamer-Functionalized Cationic Liposome for Synergistic Anti-Breast Cancer Effects In Vivo
- (2019) Sheng Yu et al. Journal of Biomedical Nanotechnology
- Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells
- (2019) Tayebeh Saleh et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells
- (2019) Yinxing Shen et al. International Journal of Nanomedicine
- A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery
- (2019) Marzieh Baneshi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer
- (2019) Xin Li et al. BIOMEDICINE & PHARMACOTHERAPY
- HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation
- (2019) Tao Duan et al. BIOMEDICINE & PHARMACOTHERAPY
- HER2-targeted therapies — a role beyond breast cancer
- (2019) Do-Youn Oh et al. Nature Reviews Clinical Oncology
- Selective eradication of human non-small cell lung cancer cells using aptamer-decorated nanoparticles harboring a cytotoxic drug cargo
- (2019) Shira Engelberg et al. Cell Death & Disease
- Endocytic Pathways and Intracellular Transport of Aptamer-Drug Conjugates in Live Cells Monitored by Single-Particle Tracking
- (2019) Cheng Lv et al. ANALYTICAL CHEMISTRY
- AS1411 aptamer modified carbon dots via polyethylenimine‐assisted strategy for efficient targeted cancer cell imaging
- (2019) Tingting Kong et al. CELL PROLIFERATION
- EpCAM Aptamer-Functionalized Cationic Liposome-Based Nanoparticles Loaded with miR-139-5p for Targeted Therapy in Colorectal Cancer
- (2019) Yuyu Zhao et al. MOLECULAR PHARMACEUTICS
- Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers
- (2018) Gang Zhou et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeted co-delivery of epirubicin and NAS-24 aptamer to cancer cells using selenium nanoparticles for enhancing tumor response in vitro and in vivo
- (2018) Seyed Hamid Jalalian et al. CANCER LETTERS
- Multi-functionalized chitosan nanoparticles for enhanced chemotherapy in lung cancer
- (2018) Xueling Guo et al. CARBOHYDRATE POLYMERS
- Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery
- (2018) Lei Xu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer
- (2018) Meng Wu et al. DRUG DELIVERY
- Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
- (2018) Xiao-qian Dou et al. International Journal of Nanomedicine
- Vincristine-Loaded and sgc8-Modified Liposome as a Potential Targeted Drug Delivery System for Treating Acute Lymphoblastic Leukemia
- (2018) Siliang Duan et al. Journal of Biomedical Nanotechnology
- Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model
- (2018) Walhan Alshaer et al. JOURNAL OF CONTROLLED RELEASE
- Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles
- (2018) Sepideh Zununi Vahed et al. JOURNAL OF DRUG TARGETING
- Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells
- (2018) Fangyi Chen et al. Nanomedicine-Nanotechnology Biology and Medicine
- Tunable cytotoxic aptamer–drug conjugates for the treatment of prostate cancer
- (2018) Bethany Powell Gray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
- (2018) Carla Lucia Esposito et al. Molecular Therapy-Nucleic Acids
- Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2 + Breast Cancer
- (2018) Xiaolin Yu et al. Molecular Therapy-Nucleic Acids
- Gemcitabine-incorporated G-quadruplex aptamer for targeted drug delivery into pancreas cancer
- (2018) Jun Young Park et al. Molecular Therapy-Nucleic Acids
- CX-5461-loaded nucleolus-targeting nanoplatform for cancer therapy through induction of pro-death autophagy
- (2018) Yanhong Duo et al. Acta Biomaterialia
- Aptamer-guided nanomedicines for anticancer drug delivery
- (2018) Walhan Alshaer et al. ADVANCED DRUG DELIVERY REVIEWS
- A basic insight into aptamer-drug conjugates (ApDCs)
- (2018) Wenjing Xuan et al. BIOMATERIALS
- EGFR aptamer-conjugated liposome-polycation-DNA complex for targeted delivery of SATB1 small interfering RNA to choriocarcinoma cells
- (2018) Jinhua Dong et al. BIOMEDICINE & PHARMACOTHERAPY
- Curcumin-entrapped MUC-1 aptamer targeted dendrimer-gold hybrid nanostructure as a theranostic system for colon adenocarcinoma
- (2018) Mona Alibolandi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Synergistic targeting HER2 and EGFR with a bivalent aptamer-siRNA chimera efficiently inhibits HER2-positive tumor growth
- (2018) LU XUE et al. MOLECULAR PHARMACEUTICS
- Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles
- (2018) Padmanaban Sivakumar et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Treating Tumors at Low Drug Doses Using an Aptamer-Peptide Synergistic Drug Conjugate
- (2018) Anusha Pusuluri et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Aptamer-targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7-positive tumours
- (2018) Mengting Liu et al. CELL PROLIFERATION
- Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
- (2018) Funda Meric-Bernstam et al. CLINICAL CANCER RESEARCH
- Tumor-Associated Fibronectin Targeted Liposomal Nanoplatform for Cyclophilin A siRNA Delivery and Targeted Malignant Glioblastoma Therapy
- (2018) Phei Er Saw et al. Frontiers in Pharmacology
- Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer
- (2017) David Powell et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer
- (2017) Yang Li et al. International Journal of Nanomedicine
- Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA
- (2017) Jianxu Zhang et al. International Journal of Nanomedicine
- Application of aptamers in treatment and diagnosis of leukemia
- (2017) Rezvan Yazdian-Robati et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nucleolin-Targeting AS1411-Aptamer-Modified Graft Polymeric Micelle with Dual pH/Redox Sensitivity Designed To Enhance Tumor Therapy through the Codelivery of Doxorubicin/TLR4 siRNA and Suppression of Invasion
- (2017) Shudi Yang et al. MOLECULAR PHARMACEUTICS
- Self-Assembled Aptamer-Nanomedicine for Targeted Chemotherapy and Gene Therapy
- (2017) Nianxi Zhao et al. Small
- A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
- (2017) Fangfei Li et al. Nature Communications
- Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
- (2017) Dongxi Xiang et al. Theranostics
- Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth
- (2017) Sorah Yoon et al. Molecular Therapy-Nucleic Acids
- Constructing aptamer anchored nanovesicles for enhanced tumor penetration and cellular uptake of water soluble chemotherapeutics
- (2016) Xin Li et al. Acta Biomaterialia
- EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery
- (2016) Xiaodong Xie et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer
- (2016) Mehdi Esfandyari-Manesh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Prevalence of cancer chemotherapy-related problems, their relation to health-related quality of life and associated supportive care: a cross-sectional survey
- (2016) Richard Wagland et al. SUPPORTIVE CARE IN CANCER
- Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia
- (2015) Nianxi Zhao et al. BIOMATERIALS
- The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model
- (2015) Mona Alibolandi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A unique aptamer-drug conjugate for targeted therapy of multiple myeloma
- (2015) J Wen et al. LEUKEMIA
- Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors
- (2015) Dongxi Xiang et al. Theranostics
- Smart ligand: Aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy
- (2013) Xin Li et al. JOURNAL OF CONTROLLED RELEASE
- Nucleolin Targeting AS1411 Modified Protein Nanoparticle for Antitumor Drugs Delivery
- (2013) Jinhui Wu et al. MOLECULAR PHARMACEUTICS
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
- (2011) Twan Lammers et al. JOURNAL OF CONTROLLED RELEASE
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started